BRPI0602614A - use of deamified starch in extrusion - spheronization of pharmaceutical pellets - Google Patents

use of deamified starch in extrusion - spheronization of pharmaceutical pellets

Info

Publication number
BRPI0602614A
BRPI0602614A BRPI0602614A BRPI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A
Authority
BR
Brazil
Prior art keywords
spheronization
extrusion
starch
deamified
pharmaceutical pellets
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Aleksandra Dukic
Chris Vervaet
Jean Paul Remon
Paul A Altieri
Paul B Foreman
Original Assignee
Nat Starch Chem Invest
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Starch Chem Invest, Univ Gent filed Critical Nat Starch Chem Invest
Publication of BRPI0602614A publication Critical patent/BRPI0602614A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

"UTILIZAçãO DE AMIDO DESRAMIFICADO NA EXTRUSãO-ESFERONIZAçãO DE PELOTAS FARMACêUTICAS". Esta patente relaciona-se à utilização de amido desramificado na preparação de pelotas farmacêuticas por extrusão-esferonização. Tais excipientes são úteis em qualquer forma de dosagem seca, incluindo tabletes e cápsulas, tanto para liberação imediata quanto para liberação sustentada."USE OF DAMAGED STARCH IN EXTRUSION-SPHERONIZATION OF PHARMACEUTICAL PELLETS". This patent relates to the use of deamified starch in the preparation of pharmaceutical pellets by extrusion-spheronization. Such excipients are useful in any dry dosage form, including tablets and capsules, for both immediate release and sustained release.

BRPI0602614 2005-05-02 2006-04-28 use of deamified starch in extrusion - spheronization of pharmaceutical pellets BRPI0602614A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67718205P 2005-05-02 2005-05-02

Publications (1)

Publication Number Publication Date
BRPI0602614A true BRPI0602614A (en) 2006-12-26

Family

ID=37546512

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602614 BRPI0602614A (en) 2005-05-02 2006-04-28 use of deamified starch in extrusion - spheronization of pharmaceutical pellets

Country Status (3)

Country Link
CN (1) CN101024084B (en)
BR (1) BRPI0602614A (en)
ZA (1) ZA200603392B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010048389A2 (en) * 2008-10-23 2010-04-29 Henkel Corporation Pharmaceutical pellets comprising modified starch and therapeutic applications therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US5468286A (en) * 1989-10-25 1995-11-21 National Starch And Chemical Investment Holding Corporation Enzymatically debranched starches as tablet excipients
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch

Also Published As

Publication number Publication date
CN101024084B (en) 2012-07-04
CN101024084A (en) 2007-08-29
ZA200603392B (en) 2007-01-31

Similar Documents

Publication Publication Date Title
PT1765314T (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES AND SYMPTOMS IN RUMATOID ARTHRITIS
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
CO6321225A2 (en) SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT
IL187475A (en) Oral solid dosage form comprising a first population of microparticles for the modified release of at least one analgesic active principle and a second population of microparticles containing at least one quenching agent and uses thereof
CU20080052A7 (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
EP2131848A4 (en) COMPOSITIONS AND METHODS FOR POTENTIATING THE ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES
DK1545467T3 (en) Solid pharmaceutical formulations comprising telmisartan
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
CL2004000930A1 (en) COMPOUND DERIVED FROM DEFINED FORMULA DIHYDROQUINAZOLINE, USEFUL FOR THE TREATMENT AND / OR PROFILAXIS OF VIRAL INFECTIONS; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND AND USE OF THE COMPOUND IN THE PREPARATION OF MEDICINES.
SK4325U (en) Sustained release pharmaceutical composition
DK200900115U1 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
CO6270217A2 (en) GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
NO20082047L (en) Slow release composition, process for its preparation and use thereof
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2008003799A1 (en) Pharmaceutical composition comprising raloxifene in immediate release tablet form; Useful for the treatment and / or prevention of osteoporosis.
ATE327759T1 (en) SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
ATE448780T1 (en) MODIFIED RELEASE PHARMACEUTICAL MODAFINIL COMPOSITIONS
ITFI20050041A1 (en) HYDROXAMMED AS INHIBITORS OF ISTONE DEACELITASIS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
BRPI0602614A (en) use of deamified starch in extrusion - spheronization of pharmaceutical pellets
IL184628A0 (en) Indan amide derivatives possessing glycogen phosphorylase inhibitory activity, processes for their manufacture, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments to inhibit glycogen phosphorylase activity in warm-blooded animals
IL180209A (en) Pharmaceutical preparations including selective and specific inhibitor of sinus stream and calcium inhibitor and uses
BRPI0614413A2 (en) compound and pharmaceutical composition

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Maintenance of archiving: application remains archived as no request for restauration (art. 87) has been received.

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 5A E 6A ANUIDADES.